Seek and Find: Current Prospective Evidence for Prostate-specific Membrane Antigen Imaging to Detect Recurrent Prostate Cancer
出版年份 2021 全文链接
标题
Seek and Find: Current Prospective Evidence for Prostate-specific Membrane Antigen Imaging to Detect Recurrent Prostate Cancer
作者
关键词
Prostate-specific membrane antigen, Ga-PSMA-11, F-DCFPyL, Positron emission tomography, Recurrent prostate cancer, Imaging biomarker, Prospective
出版物
European Urology Focus
Volume 7, Issue 2, Pages 267-278
出版商
Elsevier BV
发表日期
2021-03-20
DOI
10.1016/j.euf.2021.03.012
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase 3, Multicenter Study
- (2021) Michael J. Morris et al. CLINICAL CANCER RESEARCH
- A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate-Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)
- (2021) Kenneth J. Pienta et al. JOURNAL OF UROLOGY
- Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
- (2020) Silke Gillessen et al. EUROPEAN UROLOGY
- Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial.
- (2020) Piet Ost et al. JOURNAL OF CLINICAL ONCOLOGY
- Multi-phasic 68Ga-PSMA PET/CT in detection of early recurrence in prostate cancer patients with PSA < 1 ng/ml: a prospective study of 135 cases.
- (2020) Mohsen Beheshti et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy
- (2020) Désirée Deandreis et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer
- (2020) Stefan A. Koerber et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
- (2020) Michael S Hofman et al. LANCET
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
- (2020) Ryan Phillips et al. JAMA Oncology
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) C. Parker et al. ANNALS OF ONCOLOGY
- The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a single-centre, prospective clinical trial
- (2020) A. Joshi et al. CLINICAL & EXPERIMENTAL METASTASIS
- False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial
- (2020) Wolfgang P. Fendler et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective evaluation of 68Ga-PSMA-11 PET/CT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time after prostatectomy, and serum PSA level
- (2020) Liang Dong et al. MEDICAL ONCOLOGY
- Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
- (2019) Jeremie Calais et al. BMC CANCER
- Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy
- (2019) Usman Bashir et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer
- (2019) Wolfgang P. Fendler et al. JAMA Oncology
- A multicentre prospective clinical trial of 68Gallium PSMA HBED-CC PET-CT restaging in biochemically relapsed prostate carcinoma: Oligometastatic rate and distribution, compared to standard imaging
- (2019) Michael McCarthy et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
- (2019) Marlon Perera et al. EUROPEAN UROLOGY
- Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy
- (2019) Lino M. Sawicki et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer
- (2019) Courtney Lawhn-Heath et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- How does 68 Ga‐prostate‐specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?
- (2019) Lorenzo Bianchi et al. INTERNATIONAL JOURNAL OF UROLOGY
- A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
- (2019) Etienne Rousseau et al. JOURNAL OF NUCLEAR MEDICINE
- Adjuvant And Salvage Radiotherapy After Prostatectomy: Aua/Astro Guideline Amendment 2018
- (2019) Thomas M. Pisansky et al. JOURNAL OF UROLOGY
- Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy
- (2019) Mohammad Abufaraj et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure after Radical Prostatectomy for Prostate Cancer
- (2019) Steven P. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of three interpretation criteria of 68Ga-PSMA11 PET based on inter- and intra-reader agreement
- (2019) Akira Toriihara et al. JOURNAL OF NUCLEAR MEDICINE
- A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy
- (2019) Wei Liu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prospective Evaluation in an Academic Center of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer: A Focus on Localizing Disease and Changes in Management
- (2019) Hong Song et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-DCFPyL PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy
- (2019) Esther Mena et al. JOURNAL OF NUCLEAR MEDICINE
- 3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy. Results of a prospective multi-center trial.
- (2019) Louise Emmett et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml
- (2019) Ewa Witkowska-Patena et al. PROSTATE CANCER AND PROSTATIC DISEASES
- 68 Ga-PSMA PET/CT in Patients with Rising Prostatic-Specific Antigen After Definitive Treatment of Prostate Cancer: Detection Efficacy and Diagnostic accuracy
- (2018) Maged Abdel Galil Hamed et al. ACADEMIC RADIOLOGY
- 68Ga-PSMA PET/CT in Patients With Biochemical Recurrence of Prostate Cancer
- (2018) Helle D. Zacho et al. CLINICAL NUCLEAR MEDICINE
- 68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients
- (2018) Paola Caroli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Detection efficacy of [18F]PSMA-1007 PET/CT in 251 Patients with biochemical recurrence after radical prostatectomy
- (2018) Frederik L. Giesel et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancer
- (2018) Elif Neslihan Akdemir et al. WORLD JOURNAL OF UROLOGY
- A Prospective, Multi-site, International Comparison of F-18 fluoro-methyl-choline, multi-parametric magnetic resonance and Ga-68 HBED-CC (PSMA-11) in men with High-Risk Features and Biochemical Failure after Radical Prostatectomy: Clinical Performance and Patient Outcomes
- (2018) Louise Emmett et al. JOURNAL OF NUCLEAR MEDICINE
- Meta-analysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology
- (2018) Thomas A. Hope et al. JOURNAL OF NUCLEAR MEDICINE
- Rapid modulation of PSMA expression by Androgen deprivation: Serial 68Ga PSMA-11 PET in men with hormone sensitive and castrate resistant prostate cancer commencing androgen blockade.
- (2018) Louise M Emmett et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical impact of PSMA-based 18F–DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy
- (2017) Esther Mena et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Impact of68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence
- (2017) Jeremie Calais et al. JOURNAL OF NUCLEAR MEDICINE
- Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
- (2017) Matthias Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Impact of68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer
- (2017) Thomas A. Hope et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study
- (2017) Wolfgang Peter Fendler et al. JOURNAL OF NUCLEAR MEDICINE
- The Impact of68Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study
- (2017) Paul J. Roach et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
- (2016) Pim J. van Leeuwen et al. BJU INTERNATIONAL
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
- (2016) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- PSA-Stratified Performance of 18 F- and 68 Ga-PSMA PET in Patients with Biochemical Recurrence of Prostate Cancer
- (2016) Felix Dietlein et al. JOURNAL OF NUCLEAR MEDICINE
- PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
- (2016) Steven P. Rowe et al. MOLECULAR IMAGING AND BIOLOGY
- Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
- (2015) M. Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP)
- (2015) JNCI-Journal of the National Cancer Institute
- The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP)
- (2015) JNCI-Journal of the National Cancer Institute
- PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
- (2012) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis
- (2009) Sebastian Mannweiler et al. PATHOLOGY & ONCOLOGY RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation